SiNtx Technologies, Inc. SINT 深 滬
等待開盤 03-26 09:30:00 美东时间
2.56
-0.010
-0.39%
華盛通- 最 高2.63
- 今 開2.62
- 成交量 8501股
- 最 低 2.55
- 昨 收 2.57
- 總市值 986.11万
- 52周最高 6.78
- 市盈率 靜 --
- 換手率 0.22%
- 52周最低 1.71
- 委 比 -67.36%
- 總股本 385.20万
- 歷史最高 209400.00
- 量 比 0.17
- 振 幅 3.11%
- 歷史最低 1.71
- 每 手 1
- 風險率 0.66%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BUZZ-SINTX rises after first use of FDA-cleared implant, names new president
BUZZ-SINTX rises after first use of FDA-cleared implant, names new president ** Shares of biomaterials maker SINTX Technologies SINT.O rise 7% to $2.75 ** Co says a surgeon performed the first human surgery using its FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System, marking SINTX's entry int
03-23 21:59
快讯 | SINTX Technologies提供了企业业务更新，重点介绍了首次人体植入、战略转型和商业执行情况。
SINTX Technologies Provides Corporate Business Update Highlighting First Human ...
03-23 21:15
SINTX Technologies Completes First-In-Human Surgical Procedure Utilizing FDA-Cleared SINAPTIC Foot & Ankle Osteotomy Wedge System
Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platformSALT LAKE CITY, Utah, March 19, 2026 (GLOBE NEWSWIRE)
03-19 19:39
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
SiNtx Technologies successfully completed the first-in-human surgical procedure using its FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System, marking a major clinical and commercial milestone. This entry into the foot and ankle reconstruction market advances the commercialization of its silicon nitride biomaterial platform. The system, cleared in October 2025, integrates surgeon-informed design with silicon nitride technology, showcasing os...
03-19 11:30
SINTX Names Ryan Elmore President on $375,000 Salary With $100,000 Sign-On Bonus and $300,000 RSU Grant
SINTX Names Ryan Elmore President on $375,000 Salary With $100,000 Sign-On Bonus and $300,000 RSU Grant SINTX Technologies Inc. entered into an executive employment agreement with incoming President Ryan Elmore, effective Feb. 6, 2026, with employment beginning March 16, 2026. The deal provides a $3
02-18 21:36
SINTX Technologies Names Ryan Elmore President
SINTX Technologies Names Ryan Elmore President SINTX Technologies Inc. appointed Ryan Elmore as President, effective March 16, 2026. Elmore previously served as Core Business Director at Invibio and will lead SINTX’s channel expansion and commercialization efforts for its silicon nitride biomaterial
02-18 21:30
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms
SINTX Technologies appoints Ryan Elmore as President to accelerate revenue growth through its SiNERGY silicon nitride devices and antipathogenic fibrous materials. Elmore brings over 15 years of experience in biomaterials and medical device commercialization. His role includes leading commercialization efforts, expanding product categories, and enhancing manufacturing capabilities to support various applications. SINTX aims to leverage its propri...
02-18 13:30
SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5
SINTX Technologies, Inc. announced its participation in the Noble Capital Markets Emerging Growth Virtual Equity Conference on February 4–5, 2026. Following operational restructuring and enhanced financial discipline, the company aims to showcase its progress and strategic priorities, including its silicon-nitride-based biomaterial platform and opportunities in orthopedic and spine applications. Interested investors can schedule meetings via Sint...
01-29 14:00
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
SINTX Technologies Inc. Chief Investment Officer Gregg R. Honigblum Acquires Common Shares
Gregg R. Honigblum, Chief Investment Officer and Director of SINTX Technologies Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below. D...
2025-12-08 21:00
